arrow
S

Samvel B. Gasparyan

AstraZeneca
H指数:13
被引数:913

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Balcinrenone in combination with dapagliflozin compared with dapagliflozin alone in patients with chronic kidney disease and albuminuria: a randomised, active-controlled double-blind, phase 2b clinical trial

巴西利克莫酮联合达格列净与达格列净单药治疗慢性肾脏病合并白蛋白尿患者的比较:一项随机、活性对照、双盲、2b期临床试验

2025-11-080
PRE
Balcinrenone plus dapagliflozin in patients with heart failure and chronic kidney disease: Results from the phase 2b MIRACLE trial

Balcinrenone联合dapagliflozin治疗心力衰竭和慢性肾病患者: 2b期奇迹试验的结果

2024-05-237
OA
Effect of Dapagliflozin on Total Heart Failure Events in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction A Prespecified Analysis of the DELIVER Trial
2023-06-019
OAAI
Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER
2022-08-27162
OAAI
Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure With Reduced Ejection Fraction An Analysis of DAPA-HF

射血分数降低的心力衰竭患者的达格列净和复发性心力衰竭住院治疗dapa-hf分析

2021-05-1840
OAAI